Prevalence of anti-HCV positivity in hemodialysis and renal transplant patients at our center
Bilgin, N.; Simşek, H.; Haberal, M.
Transplantation Proceedings 25(6): 3261-3262
1993
ISSN/ISBN: 0041-1345 PMID: 7505501 Document Number: 419085
Document emailed within 1 workday
Related Documents
Gohar, S.A.; Khalil, R.Y.; Elaish, N.M.; Khedr, E.M.; Ahmed, M.S. 1995: Prevalence of antibodies to hepatitis C virus in hemodialysis patients and renal transplant recipients Journal of the Egyptian Public Health Association 70(5-6): 465-484Mirza, S.; Mahmud, S.N.; Abideen, Z.U.; Aziz, T.; Akhter, S.; Baloch, B.K. 2019: Overcoming the Immunological Barrier in Highly HLA Sensitized Renal Transplant Recipients - a Desensitization Experience from a Transplant Center in Pakistan JPMA. Journal of the Pakistan Medical Association 69(4): 584-587
Techawathanawanna, N.; Avihingsanon, Y.; Praditpornsilpa, K.; Kingpetch, K.; Suwanwalaikorn, S.; Kanjanabuch, T.; Eiam-Ong, S.; Tungsanga, K. 2005: The prevalence and risk factors of osteoporosis in Thai renal-transplant patients Journal of the Medical Association of Thailand 88(Suppl 4): S103-S109
Kosch, M.; Könecke, J.; Hausberg, M.; Kisters, K. 2001: Incidence of de novo malignancies in renal transplant patients after anti-T-lymphocytic therapy Clinical Nephrology 56(6): S35-S36
Wu, P.; Everly, M.J.; Jin, J.; Mao, Y.; Chen, J. 2011: Understanding the significance of low-level preformed donor-specific anti-HLA antibodies in renal transplant patients Clinical Transplants 2011: 365-368
Sauceda, L.F.; Gutiérrez, R.; Franco, M.; Beltrán, A. 1999: Prevalence of anti-HIV antibodies in patients at the Service of Human Reproduction Biology of the "20th November" National Medical Center Ginecologia y Obstetricia de Mexico 67: 459-460
Zer, Y.; Karaoğlan, I.; Ciçek, H.ül.; Karağoz, I.şi.D.; Sağlam, M. 2009: Evaluation of the patients with low levels of anti-HCV positivity Mikrobiyoloji Bulteni 43(1): 133-139
Yildirim, M.; Yavuz, M.T.; Ozdemir, D.; Behçet, M.; Sencan, I. 2008: High rate of hepatitis B virus DNA positivity in anti-HBc only-positive patients Mikrobiyoloji Bulteni 42(3): 535-536
Thanakitcharu, P.; Jirajan, B. 2016: Prevalence of Hemoglobin Cycling and its Clinical Impact on Outcomes in Thai End-Stage Renal Disease Patients Treated with Hemodialysis and Erythropoiesis-Stimulating Agent Journal of the Medical Association of Thailand 99(Suppl 2): S28-S37
Ceri, M.; Unverdi, S.; Altay, M.; Ureten, K.; Oztürk, M.A.; Gönen, N.; Duranay, M. 2010: Anti-cyclic citrullinated peptides positivity rate in patients with familial Mediterranean fever Clinical and Experimental Rheumatology 28(4 Suppl 60: S58-S61
Ruangkanchanasetr, P.; Lauhawatana, B.; Leawseng, S.; Kitpanich, S.; Lumpaopong, A.; Thirakhupt, P. 2012: Malignancy in renal transplant recipients: a single-center experience in Thailand Journal of the Medical Association of Thailand 95(Suppl 5): S12-S16
Belbrik, S.; Marie, A.; Boudailliez, B.; Morinière, P.; Sébert, J.L.; Solal, M.C.; Westeel, P.F.; Roche, D.; Fournier, A. 1990: Prevalence of histological types of bone disease in a hemodialysis center limiting the oral intake of aluminum hydroxide Nephrologie 11(2): 83-90
Corry, R.J.; Oei, L.S.; Freeman, R.M.; Thompson, J.S. 1978: Major factors affecting cadaver renal transplant outcome in a single center Proceedings of the Clinical Dialysis and Transplant Forum 8: 226-231
Stiller, C.; Keown, P. 1990: Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy Transplantation Proceedings 22(3): 1253-1254
Mendez, R.; Mendez, R.G.; Cicciarelli, J.; Meihaus, J.; Boken, R.; Bogaard, T.; Chaballout, A. 1991: Matching, race, donor age, and cold ischemia effects at a single renal transplant center Transplantation Proceedings 23(1 Part 1): 376-377
Okada, K.; Kuno, T.; Yanai, M.; Maeda, H.; Takahashi, S.; Hatano, M. 1988: The effects of CaCO3 on renal osteodystrophy--comparison of patients with chronic renal failure in the predialytic stage and patients undergoing maintenance hemodialysis Nihon Jinzo Gakkai Shi 30(8): 1053-1062
Boyce, N.; Holdsworth, S.; Atkins, R.; Dowling, J. 1985: De-novo anti-GBM-antibody-induced glomerulonephritis in a renal transplant Clinical Nephrology 23(3): 148-151
Azevedo, H.A.; Villela-Nogueira, C.A.; Perez, R.M.; Segadas-Soares, J.A.; Takahashi, C.; Gaburo, N.; Pessoa, I.; Coelho, H.Sérgio.M. 2007: Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function Journal of Nephrology 20(5): 609-616
Tuckman, J.; Reubi, F.; Vorburger, C.; Hodler, J. 1973: Hemodynamics of repetitive hemodialysis and kidney transplant patients Journal d'Urologie et de Nephrologie 79(4): 366-367
Ibels, L.S.; Stewart, J.H.; Mahony, J.F.; Neale, F.C.; Sheil, A.G. 1977: Occlusive arterial disease in uraemic and haemodialysis patients and renal transplant recipients. A study of the incidence of arterial disease and of the prevalence of risk factors implicated in the pathogenesis of arteriosclerosis Quarterly Journal of Medicine 46(182): 197-214